Literature DB >> 21273306

E47 regulates hematopoietic stem cell proliferation and energetics but not myeloid lineage restriction.

Qi Yang1, Brandt Esplin, Lisa Borghesi.   

Abstract

The immune system is replenished by self-renewing hematopoietic stem cells (HSCs) that produce multipotent progenitors (MPPs) with little renewal capacity. E-proteins, the widely expressed basic helix-loop-helix transcription factors, contribute to HSC and MPP activity, but their specific functions remain undefined. Using quantitative in vivo and in vitro approaches, we show that E47 is dispensable for the short-term myeloid differentiation of HSCs but regulates their long-term capabilities. E47-deficient progenitors show competent myeloid production in short-term assays in vitro and in vivo. However, long-term myeloid and lymphoid differentiation is compromised because of a progressive loss of HSC self-renewal that is associated with diminished p21 expression and hyperproliferation. The activity of E47 is shown to be cell-intrinsic. Moreover, E47-deficient HSCs and MPPs have altered expression of genes associated with cellular energy metabolism, and the size of the MPP pool but not downstream lymphoid precursors in bone marrow or thymus is rescued in vivo by antioxidant. Together, these observations suggest a role for E47 in the tight control of HSC proliferation and energy metabolism, and demonstrate that E47 is not required for short-term myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273306      PMCID: PMC3072876          DOI: 10.1182/blood-2010-07-297689

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins.

Authors:  S Prabhu; A Ignatova; S T Park; X H Sun
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Both E12 and E47 allow commitment to the B cell lineage.

Authors:  G Bain; E C Robanus Maandag; H P te Riele; A J Feeney; A Sheehy; M Schlissel; S A Shinton; R R Hardy; C Murre
Journal:  Immunity       Date:  1997-02       Impact factor: 31.745

3.  High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice.

Authors:  W Yan; A Z Young; V C Soares; R Kelley; R Benezra; Y Zhuang
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

Review 4.  Molecular resolution of the B cell landscape.

Authors:  Patricia M Santos; Lisa Borghesi
Journal:  Curr Opin Immunol       Date:  2011-01-12       Impact factor: 7.486

5.  New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia.

Authors:  D L Williams; A T Look; S L Melvin; P K Roberson; G Dahl; T Flake; S Stass
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

6.  The aging of hematopoietic stem cells.

Authors:  S J Morrison; A M Wandycz; K Akashi; A Globerson; I L Weissman
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

7.  E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas.

Authors:  G Bain; I Engel; E C Robanus Maandag; H P te Riele; J R Voland; L L Sharp; J Chun; B Huey; D Pinkel; C Murre
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

8.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1.

Authors:  T Cheng; N Rodrigues; H Shen; Y Yang; D Dombkowski; M Sykes; D T Scadden
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

9.  B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB.

Authors:  Y Zhuang; P Cheng; H Weintraub
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  Tests for finding complex patterns of differential expression in cancers: towards individualized medicine.

Authors:  James Lyons-Weiler; Satish Patel; Michael J Becich; Tony E Godfrey
Journal:  BMC Bioinformatics       Date:  2004-08-12       Impact factor: 3.169

View more
  18 in total

Review 1.  Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells.

Authors:  Julie R Boiko; Lisa Borghesi
Journal:  Cytokine       Date:  2011-11-12       Impact factor: 3.861

Review 2.  Transcriptional and epigenetic regulation of B cell development.

Authors:  Patricia Santos; Fortuna Arumemi; Kyung Soo Park; Lisa Borghesi; Christine Milcarek
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 3.  Hematopoietic stem cells: concepts, definitions, and the new reality.

Authors:  Connie J Eaves
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

Review 4.  Hematopoiesis in steady-state versus stress: self-renewal, lineage fate choice, and the conversion of danger signals into cytokine signals in hematopoietic stem cells.

Authors:  Lisa Borghesi
Journal:  J Immunol       Date:  2014-09-01       Impact factor: 5.422

5.  Flk2/Flt3 promotes both myeloid and lymphoid development by expanding non-self-renewing multipotent hematopoietic progenitor cells.

Authors:  Anna E Beaudin; Scott W Boyer; E Camilla Forsberg
Journal:  Exp Hematol       Date:  2013-12-11       Impact factor: 3.084

6.  Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.

Authors:  Nickolas Steinauer; Chun Guo; Chunfa Huang; Madeline Wong; Yifan Tu; Carl E Freter; Jinsong Zhang
Journal:  Blood Adv       Date:  2019-05-14

7.  Transcription elongation factor ELL2 drives Ig secretory-specific mRNA production and the unfolded protein response.

Authors:  Kyung Soo Park; Ian Bayles; Alec Szlachta-McGinn; Joshua Paul; Julie Boiko; Patricia Santos; June Liu; Zhou Wang; Lisa Borghesi; Christine Milcarek
Journal:  J Immunol       Date:  2014-09-19       Impact factor: 5.422

8.  Cell-intrinsic in vivo requirement for the E47-p21 pathway in long-term hematopoietic stem cells.

Authors:  Patricia M Santos; Ying Ding; Lisa Borghesi
Journal:  J Immunol       Date:  2013-11-20       Impact factor: 5.422

9.  The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells.

Authors:  Lela Kardava; Qi Yang; Anthony St Leger; Kenneth A Foon; Suzanne Lentzsch; Abbe N Vallejo; Christine Milcarek; Lisa Borghesi
Journal:  Int Immunol       Date:  2011-05-06       Impact factor: 4.823

10.  Mtg16/Eto2 contributes to murine T-cell development.

Authors:  Aubrey Hunt; Melissa Fischer; Michael E Engel; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.